SIPC.CA Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: December 29, 2025
Report Source: 2025 3rd Quarter Report
Sabaa International Company for Pharmaceutical & Chemical Industries. Stock Analysis SIPC.CA
SABAA Int'l Co for Pharmaceutical & Chemical Industries SAE engages in the manufacture, marketing, and sale of pharmaceuticals, chemicals, cosmetics, veterinary drugs, and medical equipment. The company is headquartered in Cairo, Cairo. The company went IPO on 2013-10-10. The Company’s generic product portfolio includes products focused on different therapeutic categories. The Company’s products include Acitretin, Saboctic, Topiramate, Moxifloxacin, Claudol, among others.
Read More Sabaa International Company for Pharmaceutical & Chemical Industries (SIPC.CA) Chart
Key Statistics of Sabaa International Company for Pharmaceutical & Chemical Industries (SIPC.CA)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
EGP3.69Volume
3.30MP/E Ratio (TTM)
-52 Week Range
Market Cap
890.00MAvg. Volume
5.78MDividend Yield
-Financial Metrics & Statements of Sabaa International Company for Pharmaceutical & Chemical Industries (SIPC.CA)
Community-Curated Collections with Sabaa International Company for Pharmaceutical & Chemical Industries (SIPC.CA) ( With SIPC.CA )
View AllCommunity-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.
FAQ's for Sabaa International Company for Pharmaceutical & Chemical Industries (SIPC.CA)
- According to Musaffa’s Shariah screening methodology, Sabaa International Company for Pharmaceutical & Chemical Industries (SIPC.CA) is currently classified as HALAL as of December 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.